TP53 and glioblastoma: The aim of this study was to evaluate GATA4 protein expression, GATA4 promoter methylation, and TP53 status (mutations, promoter methylation, and protein expression) in patients with primary glioblastoma and assess the possible prognostic impact of these changes on the overall survival rate.